{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-098461","form_type":"8-K","ticker":"RGEN","cik":"0000730272","company_name":"REPLIGEN CORP","filed_at":"2023-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.100677+00:00","generated_at":"2026-06-17T03:23:52.498820+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"low","headline":"Repligen announces acquisition of FlexBiosys for undisclosed cash, equity, and earnout","bullets":["Repligen executed Equity Purchase Agreement to acquire all outstanding equity of FlexBiosys.","Consideration comprises cash, equity, and performance-based earnout payments through year-end 2024.","Transaction expected to close in Q2 2023, subject to satisfaction of conditions.","No financial terms or valuation were disclosed in the SEC filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-098461","json":"https://secwatch.observer/filing/0001193125-23-098461.json","markdown":"https://secwatch.observer/filing/0001193125-23-098461.md","text":"https://secwatch.observer/filing/0001193125-23-098461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730272/000119312523098461/0001193125-23-098461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730272/000119312523098461/d460811d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T03:23:52.498820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}